3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
11
Phase 2
3
Phase 2/3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Anus Neoplasms
2
Virus Diseases
1
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Interventions
Gemcitabine
4
Cisplatin
2
vinflunine
1
valrubicin
1
pembrolizumab
1
enfortumab vedotin
1
cabazitaxel
1
XRP6258
1
Rogaratinib
1
Oncolytic Virotherapy
1
Mitomycin
1
Interferons
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Carcinoma, Transitional Cell
×
Mitomycin
×
Clear all
NCT01438112
2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3
Terminated
22 enrolled